January 1, 2025 - 13:32

As 2024 comes to a close, the US market averages, including the Dow Jones Industrial Average, Nasdaq Composite, and S&P 500, have shown impressive annual gains despite a recent dip. The Nasdaq Composite, in particular, has surged by over 28% this year, reflecting strong performance in the technology sector.
Jared Blikre, host of Market Domination Overtime, provided a comprehensive assessment of the year’s market dynamics. He noted a significant shift towards the Russell 2000 small-cap index, which has been indicative of broader economic trends and investor sentiment. Mid-year volatility, marked by fluctuations in the volatility index, added an element of unpredictability but ultimately did not overshadow the overall positive trajectory of the markets.
In addition to equities, the bond market also reached notable highs, demonstrating resilience and attracting investor interest. The year has been characterized by a complex interplay of factors influencing both stocks and bonds, setting the stage for an intriguing start to 2025.
May 8, 2026 - 06:21
Broadcom OpenAI Financing Snag Puts AI Growth And Valuation In FocusBroadcom is reportedly hitting a financial roadblock in its partnership with OpenAI, with an $18 billion financing snag threatening a major custom AI chip deal. The issue centers on the funding...
May 7, 2026 - 18:12
Whitmire's Budget Plan: New Fee, No Tax Hike, and a Push for Structural ChangeHouston Mayor John Whitmire has unveiled a budget proposal that aims to reshape the city`s financial foundation without raising property taxes. The plan introduces a new fee while holding the line...
May 7, 2026 - 02:52
Assessing TFS Financial (TFSL) Valuation After Second Quarter Earnings And Continued Growth In Net IncomeTFS Financial (TFSL) reported its second quarter results, posting net interest income of US$77.81 million and net income of US$23.25 million. The company also showed modest earnings per share...
May 6, 2026 - 19:46
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate ProgressRevolution Medicines has released its financial results for the first quarter of 2026, alongside a significant update on its clinical pipeline. The company announced that its drug candidate...